Literature DB >> 7690791

The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.

L E Bradbury1, V S Goldmacher, T F Tedder.   

Abstract

CD19 expressed on the surface of B lymphocytes is a key member of a cell surface signal transduction complex that includes TAPA-1, Leu 13 and CD21. The human CD19 protein is composed of 540 amino acids with a cytoplasmic domain of 242 amino acids. Although the cytoplasmic domain of CD19 has no sequence homology with other proteins, the cytoplasmic domain of human, mouse, and guinea pig CD19 is highly conserved suggesting that this region of CD19 is at least partially responsible for signaling activity. In this study, the regions of CD19 required for intermolecular associations and signal transduction were determined by comparing a series of carboxyl-terminal cytoplasmic tail deletion mutants and a CD19/L-selectin chimera with native CD19. CD19 expressed in the human Rex T cell line and the K562 erythroleukemia cell line generated transmembrane signals and also associated with endogenous TAPA-1. Deletion of 95% of the CD19 cytoplasmic domain did not affect the ability of CD19 to be expressed or to associate with TAPA-1. However, replacement of the CD19 transmembrane and cytoplasmic domains with those of L-selectin (CD19-LAM) resulted in the loss of CD19 complex formation, suggesting that the membrane spanning domain is critical for this association. Similarly, the induction of homotypic adhesion through CD19 or truncated CD19 was equivalent, whereas homotypic adhesion was not induced via the CD19-LAM chimera. In addition, the cytoplasmic domain was not necessary for CD19 mAb-mediated growth inhibition or internalization. In contrast, the CD19 cytoplasmic domain was required for optimal mAb-induced increases in [Ca2+]i in CD19 cDNA-transfected Rex cells. Thus, the CD19 cytoplasmic domain is responsible for the induction of increased [Ca2+]i, and the transmembrane region is required for cell surface associations with the other members of the CD19 complex and most signaling events. Therefore, mAb binding to CD19 is likely to initiate multiple intracellular signal transduction cascades either through CD19 directly, or through other members of the CD19 complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.

Authors:  L Zaliauskiene; S Kang; C G Brouillette; J Lebowitz; R B Arani; J F Collawn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Specific recognition of macroscopic objects by the cell surface: evidence for a receptor density threshold revealed by micrometric particle binding characteristics.

Authors:  Stéphanie Sarda; David Pointu; Frédéric Pincet; Nelly Henry
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

3.  Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Chiung-Chi Kuo; Joseph Haimovich; Shoshana Levy
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).

Authors:  F Berditchevski; M M Zutter; M E Hemler
Journal:  Mol Biol Cell       Date:  1996-02       Impact factor: 4.138

5.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 6.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

7.  A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.

Authors:  Jonathan C Poe; Veronique Minard-Colin; Evgueni I Kountikov; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

8.  Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss.

Authors:  Donna A Culton; Matilda W Nicholas; Donna O Bunch; Quan Li Zhen; Thomas B Kepler; Mary Anne Dooley; Chandra Mohan; Patrick H Nachman; Stephen H Clarke
Journal:  J Clin Immunol       Date:  2006-12-29       Impact factor: 8.317

9.  Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.

Authors:  Jason Twohig; Liudmila Kulik; Catherine Haluszczak; Jason Reuter; Andreas Rossbach; Melanie Bull; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

Review 10.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.